Skip to content

Adaptive Biotechnologies ADPT Other Working Capital

Other Working Capital at other companies

Guardant Health logo
Guardant HealthGH
$727K+142%
GeneDx Holdings logo
GeneDx HoldingsWGS
$1.03M+36.6%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$8.52M+310%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$3K-127%
Agilent Technologies logo
Agilent TechnologiesA
$284M+51.9%
Quest Diagnostics logo
Quest DiagnosticsDGX
$31M+163%

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's other working capital?
Adaptive Biotechnologies (ADPT) reported other working capital of $98K in Q1 2026.
How has Adaptive Biotechnologies's other working capital changed year-over-year?
Adaptive Biotechnologies's other working capital increased by 1533.3% year-over-year, from $6K to $98K.
What is the long-term trend for Adaptive Biotechnologies's other working capital?
Over 2 years (2021 to 2025), Adaptive Biotechnologies's other working capital has grown at a -28.1% compound annual growth rate (CAGR), from $275K to -$142K.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.